- Home
- FBLG
FBLG
FIBROBIOLOGICS INC
as 12-20-2024 4:00pm EST
Stocks
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
| Founded: | 2021 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 91.0M | IPO Year: | 2024 |
| Target Price: | $13.00 | AVG Volume (30 days): | 126.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.57 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.08 - $46.00 | Next Earning Date: | 02-02-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest FIBROBIOLOGICS INC News
FBLG Breaking Stock News: Dive into FBLG Ticker-Specific Updates for Smart Investing
Zacks Small Cap Research
a month ago
FBLG: On Target to Initiate Phase 1/2 Trial in 2025…
MT Newswires
a month ago
FibroBiologics Files Patent Application for Methods to Treat Splenomegaly
GlobeNewswire
a month ago
FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly
GlobeNewswire
a month ago
FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics
Simply Wall St.
a month ago
Is FibroBiologics (NASDAQ:FBLG) In A Good Position To Deliver On Growth Plans?
GlobeNewswire
a month ago
FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
2 months ago
FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology
GlobeNewswire
2 months ago
FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024
Compare FBLG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "FBLG FIBROBIOLOGICS INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.